Precision BioSciences Inc...

NASDAQ: DTIL · Real-Time Price · USD
4.71
-0.06 (-1.26%)
At close: Aug 15, 2025, 3:59 PM
4.71
-0.13%
After-hours: Aug 15, 2025, 04:56 PM EDT
-1.26%
Bid 4.58
Market Cap 55.58M
Revenue (ttm) 1.26M
Net Income (ttm) -78.25M
EPS (ttm) -10.15
PE Ratio (ttm) -0.46
Forward PE -0.88
Analyst Buy
Ask 4.9
Volume 105,435
Avg. Volume (20D) 271,964
Open 4.78
Previous Close 4.77
Day's Range 4.23 - 4.90
52-Week Range 3.61 - 11.09
Beta 1.52

About DTIL

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol DTIL
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for DTIL stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Earnings Surprise

Precision BioSciences has released their quartely earnings on Aug 7, 2025:
  • Revenue of $18K misses estimates by $9.22M, with -99.96% YoY decline.
  • EPS of -2.13 misses estimates by -0.77, with -145.61% YoY decline.
  • Next Earnings Release

    Precision BioSciences Inc. is scheduled to release its earnings on Nov 3, 2025, before market opens.
    Analysts project revenue of ... Unlock content with Pro Subscription
    3 weeks ago
    +1.65%
    DTIL stock has given up its prior gain. Precision ... Unlock content with Pro Subscription
    3 weeks ago
    +1.65%
    Precision BioSciences shares are trading higher after the company was granted FDA orphan drug designation for PBGENE-DMD in Duchenne muscular dystrophy.